drugset / Trial / NCT02218684
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The trial objectives were to investigate the tolerability and pharmacokinetics of 80 mg telmisartan and 2, 4 or 6 mg lacidipine administered concurrently.
Timeline
- Start
- 1998-09
- Primary completion
- 1998-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacidipine | Small molecule | 2 mg | — |
| Subject | Lacidipine | Small molecule | 4 mg | — |
| Subject | Lacidipine | Small molecule | 6 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |
Indications
No indication recorded.